Massberg et al. obtained RNA-Seq data by high-throughput sequencing, and verified the abnormal expression of PSGR2 in prostate cancer tissues by RT-PCR, which was the highest in benign prostate tissues and almost undetectable in prostate cancer tissues, all lymph nodes and distant metastatic specimens. This evidence concerns the gene OR51E1 and Familial prostate cancer.